A 36-year-old male is brought to the emergency department for severe chest pain and vomiting. He reports sudden onset 10/10 pain concentrated along his lower chest/epigastric region that radiates to his back for the past 3 hours. He denies any precipitating event, alcohol use, exertion, biliary colic, or family history of coronary artery disease. Medical history is significant for hypertension for which he recently started taking a “water pill.” Electrocardiogram (ECG) demonstrates normal sinus rhythm, and troponins are negative. Additional laboratory findings are shown below:
Serum:
Na+: 138 mEq/L
K+: 3.9 mEq/L
Cl-: 101 mEq/L
Ca2+: 8.5 mg/dL
Total cholesterol: 210 mg/dL (Normal: < 200 mg/dL)
Triglycerides: 1,528 mg/dL (Normal: < 150 mg/dL)
CRP: 28 mg/dL (Normal: < 3 mg/dL)
Amylase: 582 U/L (Normal: 23-85 U/L)
Lipase: 1,415 U/L (Normal: 0-160 U/L)
What is the best medication for this patient in the long-term following initial stabilization?
Q32
A 49-year-old man is diagnosed with hypertension. He has asthma. The creatinine and potassium levels are both slightly elevated. Which of the following anti-hypertensive drugs would be appropriate in his case?
Q33
A 55-year-old man comes to the physician because of episodic retrosternal chest pain and shortness of breath for the past 6 months. His symptoms occur when he takes long walks or climbs stairs but resolve promptly with rest. He has a history of chronic obstructive pulmonary disease, for which he takes ipratropium bromide. His pulse is 81/min and blood pressure is 153/82 mm Hg. Physical examination shows mild expiratory wheezing over both lungs. Additional treatment with a beta blocker is considered. Which of the following agents should be avoided in this patient?
Q34
A 53-year-old man with hyperlipidemia comes to the physician for a follow-up examination. His home medications include acetaminophen and atorvastatin. Serum studies show elevated total cholesterol and triglyceride concentrations. A drug that activates the peroxisome proliferator-activated receptor alpha is added to his existing therapy. This patient is at highest risk for developing which of the following drug-related adverse effects?
Q35
A 51-year-old man presents to the urgent care center with a blood pressure of 201/111 mm Hg. He is complaining of a severe headache and chest pain. Physical examination reveals regular heart sounds and clear bilateral lung sounds. Ischemic changes are noted on his electrocardiogram (ECG). What is the most appropriate treatment for this patient’s high blood pressure?
Q36
A 67-year-old woman presents to her physician for a regular checkup. She is a community-dwelling, retired teacher without any smoking history. She has arterial hypertension and takes hydrochlorothiazide 12.5 mg and valsartan 80 mg daily. She was recently discharged from the hospital after admission for an ulnar fracture she received after a fall from the second step of a ladder in her garden. A year ago, she had a clavicular fracture from tripping over some large rocks in her yard. She does not report lightheadedness or fainting. Her medical history is also significant for an appendectomy 11 years ago. She is in menopause. She mostly consumes vegetables and dairy products. Her height is 163 cm (5 ft 4 in) and weight is 55 kg (123 lb). Her blood pressure is 130/80 mm Hg without orthostatic changes, heart rate is 73/min and regular, respiratory rate is 14/min, and temperature is 36.6°C (97.9°F). Her lungs are clear to auscultation. Cardiac auscultation reveals S2 accentuation over the aorta. The abdomen is mildly distended on palpation; there are no identifiable masses. The neurological examination is unremarkable. Considering the history and presentation, which of the following medications most likely will be prescribed to this patient after additional investigations?
Q37
A 64-year-old African American female comes to the physician's office for a routine check-up. The patient's past medical history is significant for hypertension, diabetes, and osteoarthritis in her right knee. Her medications include metformin, glimepiride, lisinopril, metoprolol, hydrochlorothiazide, and ibuprofen as needed. Her only complaint is an unremitting cough that started about 3 weeks ago and she has noticed some swelling around her mouth. The drug most likely responsible for her recent symptoms causes its primary renal hemodynamic effect on which part of the kidney?
Q38
A 68-year-old man presents for his first hemodialysis treatment. He was diagnosed with progressive chronic kidney disease 6 years ago that has now resulted in end-stage renal disease (ESRD). He currently is on a waiting list for a kidney transplant. His past medical history is significant for hypertension and peptic ulcer disease, managed with amlodipine and esomeprazole, respectively. He has diligently followed a severely restricted diet. The patient is afebrile and his vital signs are normal. His latest serum creatinine gives him an estimated glomerular filtration rate (eGFR) of 12 mL/min/1.73 m2. Which of the following should be increased as part of the management of this patient?
Q39
A 54-year-old man comes to the physician for a follow-up examination after presenting with elevated blood pressures on both arms at a routine visit 1 month ago. He feels well and takes no medications. He is 178 cm (5 ft 10 in) tall and weighs 99 kg (218 lb); BMI is 31 kg/m2. His pulse is 76/min, and blood pressure is 148/85 mm Hg on the right arm and 152/87 mm Hg on the left arm. Physical examination and laboratory studies show no abnormalities. The physician recommends lifestyle modifications in combination with treatment with hydrochlorothiazide. From which of the following embryological tissues does the site of action of this drug arise?
Q40
A 33-year-old male presents to his primary care physician with complaints of headaches and muscle weakness. His physical exam is entirely within normal limits except for a blood pressure of 150/95. Subsequent routine blood lab work showed a sodium level of 146 and potassium level of 3.0. What is the best pharmacological therapy for this patient?
Antihypertensives US Medical PG Practice Questions and MCQs
Question 31: A 36-year-old male is brought to the emergency department for severe chest pain and vomiting. He reports sudden onset 10/10 pain concentrated along his lower chest/epigastric region that radiates to his back for the past 3 hours. He denies any precipitating event, alcohol use, exertion, biliary colic, or family history of coronary artery disease. Medical history is significant for hypertension for which he recently started taking a “water pill.” Electrocardiogram (ECG) demonstrates normal sinus rhythm, and troponins are negative. Additional laboratory findings are shown below:
Serum:
Na+: 138 mEq/L
K+: 3.9 mEq/L
Cl-: 101 mEq/L
Ca2+: 8.5 mg/dL
Total cholesterol: 210 mg/dL (Normal: < 200 mg/dL)
Triglycerides: 1,528 mg/dL (Normal: < 150 mg/dL)
CRP: 28 mg/dL (Normal: < 3 mg/dL)
Amylase: 582 U/L (Normal: 23-85 U/L)
Lipase: 1,415 U/L (Normal: 0-160 U/L)
What is the best medication for this patient in the long-term following initial stabilization?
A. Aspirin
B. Atorvastatin
C. Gemfibrozil (Correct Answer)
D. Cholestyramine
E. Niacin
Explanation: ***Gemfibrozil***
- This patient presents with signs and symptoms of **acute pancreatitis** secondary to **severe hypertriglyceridemia**.
- **Fibrates** like gemfibrozil are the most effective medications for significantly lowering triglyceride levels and are indicated for treating severe hypertriglyceridemia (usually >500 mg/dL) to prevent recurrent pancreatitis.
*Aspirin*
- **Aspirin** is an antiplatelet agent primarily used for the prevention of cardiovascular events in patients with atherosclerosis.
- It does not significantly impact triglyceride levels and is not indicated for the management or prevention of hypertriglyceridemia-induced pancreatitis.
*Atorvastatin*
- **Statins** (e.g., atorvastatin) are highly effective in lowering LDL cholesterol and have a moderate effect on lowering triglycerides.
- However, for severe hypertriglyceridemia (>500 mg/dL), **fibrates** are significantly more potent in reducing triglyceride levels and preventing pancreatitis.
*Cholestyramine*
- **Cholestyramine** is a bile acid sequestrant primarily used to lower LDL cholesterol by binding bile acids in the intestine.
- It does not effectively lower triglyceride levels and can sometimes even increase them, making it inappropriate for this patient's condition.
*Niacin*
- **Niacin** (nicotinic acid) can lower both triglycerides and LDL cholesterol while raising HDL cholesterol.
- However, it is often associated with significant side effects like **flushing** and can worsen insulin resistance, and **fibrates** are generally preferred for severe hypertriglyceridemia due to a more favorable side effect profile and proven efficacy in preventing pancreatitis.
Question 32: A 49-year-old man is diagnosed with hypertension. He has asthma. The creatinine and potassium levels are both slightly elevated. Which of the following anti-hypertensive drugs would be appropriate in his case?
A. Amlodipine (Correct Answer)
B. Hydrochlorothiazide (HCT)
C. Enalapril
D. Spironolactone
E. Propranolol
Explanation: ***Amlodipine***
- **Amlodipine** is a **calcium channel blocker** that is safe and effective in patients with **asthma** as it does not exacerbate bronchoconstriction.
- It is **renal protective** and does not significantly affect **potassium levels**, making it ideal for this patient with elevated creatinine and potassium.
- This is the **best choice** given all three clinical considerations.
*Hydrochlorothiazide (HCT)*
- While generally safe in asthma, **HCT** is a **thiazide diuretic** that can worsen renal function and **increase creatinine levels**, which is problematic given the patient's already elevated creatinine.
- Although HCT causes **hypokalemia** (low potassium), it is not the preferred agent for managing hyperkalemia, and worsening renal function is a more significant concern here.
- **Amlodipine is safer overall** in this patient.
*Enalapril*
- **Enalapril** is an **ACE inhibitor** that can cause **hyperkalemia**, further worsening the patient's already elevated potassium levels.
- It can also transiently increase **creatinine**, particularly in patients with underlying renal impairment, making it an unfavorable option in this scenario.
*Spironolactone*
- **Spironolactone** is a **potassium-sparing diuretic** that frequently causes **hyperkalemia**, which would be dangerous given the patient's elevated potassium levels.
- It is **contraindicated** in patients with significant hyperkalemia or renal impairment.
*Propranolol*
- **Propranolol** is a **non-selective beta-blocker** that is **contraindicated** in patients with **asthma** as it can cause **bronchospasm** and severe respiratory compromise.
- Beta-blockers should be avoided in asthmatic patients.
Question 33: A 55-year-old man comes to the physician because of episodic retrosternal chest pain and shortness of breath for the past 6 months. His symptoms occur when he takes long walks or climbs stairs but resolve promptly with rest. He has a history of chronic obstructive pulmonary disease, for which he takes ipratropium bromide. His pulse is 81/min and blood pressure is 153/82 mm Hg. Physical examination shows mild expiratory wheezing over both lungs. Additional treatment with a beta blocker is considered. Which of the following agents should be avoided in this patient?
A. Betaxolol
B. Esmolol
C. Bisoprolol
D. Atenolol
E. Labetalol (Correct Answer)
Explanation: ***Labetalol***
- **Labetalol** is a **non-selective beta-blocker** with additional **alpha-1 blocking activity**.
- Its **non-selective beta-blocking** effects can exacerbate **bronchoconstriction** in patients with **COPD**, leading to worsening respiratory symptoms.
*Betaxolol*
- **Betaxolol** is a **beta-1 selective blocker (cardioselective)**, meaning it primarily targets the heart.
- While no beta-blocker is entirely safe in **COPD**, cardioselective agents are generally preferred due to their reduced risk of **bronchospasm**.
*Esmolol*
- **Esmolol** is an **ultra-short-acting**, **beta-1 selective blocker** often used for acute cardiac conditions.
- Its **cardioselective nature** and rapid metabolism make it relatively safer in patients with **COPD** compared to non-selective agents.
*Bisoprolol*
- **Bisoprolol** is a **highly beta-1 selective blocker** commonly used for chronic cardiac conditions.
- Its high **cardioselectivity** minimizes its impact on **bronchial beta-2 receptors**, making it a safer option for patients with **COPD**.
*Atenolol*
- **Atenolol** is a **beta-1 selective blocker** used for conditions like hypertension and angina.
- Like other cardioselective beta-blockers, it has a lower risk of causing **bronchoconstriction** in patients with **COPD** compared to non-selective agents.
Question 34: A 53-year-old man with hyperlipidemia comes to the physician for a follow-up examination. His home medications include acetaminophen and atorvastatin. Serum studies show elevated total cholesterol and triglyceride concentrations. A drug that activates the peroxisome proliferator-activated receptor alpha is added to his existing therapy. This patient is at highest risk for developing which of the following drug-related adverse effects?
A. Reddish-brown discoloration of urine (Correct Answer)
B. Bleeding from minor trauma
C. Waxing and waning confusion
D. Acutely swollen and painful joint
E. Pruritus and flushing of the skin
Explanation: ***Reddish-brown discoloration of urine***
- This patient is likely being treated with a **fibrate**, a PPAR-alpha agonist, in addition to **atorvastatin** due to persistently elevated triglycerides.
- The combination of a fibrate and a statin increases the risk of **rhabdomyolysis**, which can cause **myoglobinuria**, leading to reddish-brown urine and potential **acute kidney injury**.
*Bleeding from minor trauma*
- This adverse effect is more characteristic of **anticoagulants** (e.g., warfarin, direct oral anticoagulants) or **antiplatelet agents** (e.g., aspirin, clopidogrel).
- Fibrates and statins do not typically cause significant bleeding diathesis.
*Waxing and waning confusion*
- This can be a symptom of various conditions, including **hepatic encephalopathy**, severe electrolyte imbalances, or delirium; it is not a common adverse effect of fibrates or statins.
- While statins can rarely cause cognitive side effects, **confusion** of this nature is not a hallmark.
*Acutely swollen and painful joint*
- This symptom strongly suggests an acute **arthritic flare**, particularly **gout**, caused by hyperuricemia.
- While some medications can induce gout (e.g., diuretics), neither fibrates nor statins are commonly associated with this adverse effect.
*Pruritus and flushing of the skin*
- These are characteristic side effects of **niacin (nicotinic acid)**, another lipid-lowering agent.
- Niacin causes prostaglandin-mediated vasodilation, leading to intense **flushing and itching**, which can be severe enough to cause medication non-adherence.
Question 35: A 51-year-old man presents to the urgent care center with a blood pressure of 201/111 mm Hg. He is complaining of a severe headache and chest pain. Physical examination reveals regular heart sounds and clear bilateral lung sounds. Ischemic changes are noted on his electrocardiogram (ECG). What is the most appropriate treatment for this patient’s high blood pressure?
A. IV labetalol - lower mean arterial pressure no more than 25% over the 1st hour (Correct Answer)
B. Oral clonidine - gradually lower blood pressure over 24–48 hours
C. Oral beta-blocker - lower mean arterial pressure no more than 25% over the 1st hour
D. IV labetalol - lower mean arterial pressure no more than 50% over the 1st hour
E. IV labetalol - redose until blood pressure within normal limits
Explanation: ***IV labetalol - lower mean arterial pressure no more than 25% over the 1st hour***
- This patient presents with **hypertensive emergency**, indicated by severe hypertension (BP 201/111 mmHg) and evidence of **acute target organ damage** (severe headache, chest pain, ischemic ECG changes).
- **IV labetalol** is an appropriate first-line agent, and the goal is to **gradually reduce** the mean arterial pressure by no more than **25% within the first hour** to prevent hypoperfusion and ischemic events.
*Oral clonidine - gradually lower blood pressure over 24–48 hours*
- **Oral clonidine** has a slower onset of action and is not suitable for the **urgent reduction** required in a hypertensive emergency.
- This approach is more appropriate for **gradual blood pressure reduction** in less severe hypertension or as an adjunct in chronic management.
*Oral beta-blocker - lower mean arterial pressure no more than 25% over the 1st hour*
- **Oral medications** are generally not preferred for initial management of **hypertensive emergencies** due to their slower onset and less predictable dose titration compared to intravenous agents.
- While beta-blockers can be effective, the **oral route** is inappropriate for the acute, rapid control needed for this condition.
*IV labetalol - lower mean arterial pressure no more than 50% over the 1st hour*
- A rapid reduction of **50% in MAP** within the first hour is too aggressive and carries a significant risk of **hypoperfusion** to vital organs, potentially leading to **stroke**, **myocardial infarction**, or **renal failure**.
- The recommended initial reduction is **no more than 25%** in the first hour to maintain adequate organ perfusion.
*IV labetalol - redose until blood pressure within normal limits*
- Aggressively lowering blood pressure to **"normal limits"** too quickly can cause cerebral, cardiac, or renal **ischemia** due to loss of autoregulation in previously hypertensive patients.
- The goal is to first stabilize the patient by reducing the BP by a controlled amount, not to normalize it immediately.
Question 36: A 67-year-old woman presents to her physician for a regular checkup. She is a community-dwelling, retired teacher without any smoking history. She has arterial hypertension and takes hydrochlorothiazide 12.5 mg and valsartan 80 mg daily. She was recently discharged from the hospital after admission for an ulnar fracture she received after a fall from the second step of a ladder in her garden. A year ago, she had a clavicular fracture from tripping over some large rocks in her yard. She does not report lightheadedness or fainting. Her medical history is also significant for an appendectomy 11 years ago. She is in menopause. She mostly consumes vegetables and dairy products. Her height is 163 cm (5 ft 4 in) and weight is 55 kg (123 lb). Her blood pressure is 130/80 mm Hg without orthostatic changes, heart rate is 73/min and regular, respiratory rate is 14/min, and temperature is 36.6°C (97.9°F). Her lungs are clear to auscultation. Cardiac auscultation reveals S2 accentuation over the aorta. The abdomen is mildly distended on palpation; there are no identifiable masses. The neurological examination is unremarkable. Considering the history and presentation, which of the following medications most likely will be prescribed to this patient after additional investigations?
A. Estrogen plus progestin
B. Denosumab
C. Cholecalciferol (Correct Answer)
D. Atorvastatin
E. Tocopherol
Explanation: ***Cholecalciferol***
- The patient presents with multiple risk factors for **osteoporosis** and potential **vitamin D deficiency**, including postmenopausal status, multiple fragility fractures (ulnar and clavicular), and a diet rich in vegetables but potentially low in vitamin D-fortified products or sun exposure.
- **Cholecalciferol (Vitamin D3)** is essential for calcium absorption and bone health, and its supplementation is crucial for preventing and managing osteoporosis, particularly when low levels are suspected.
*Estrogen plus progestin*
- **Hormone replacement therapy (HRT)** with estrogen plus progestin can prevent osteoporosis, but it is typically not a first-line treatment due to increased risks of breast cancer, cardiovascular events, and stroke, especially in a 67-year-old woman.
- Given her age and that she is well past menopause, the risks often outweigh the benefits for bone health alone, and safer alternatives are available for osteoporosis treatment.
*Denosumab*
- **Denosumab** is a potent antiresorptive agent used for osteoporosis, particularly in patients with a high fracture risk or those who cannot tolerate oral bisphosphonates.
- While she has risk factors for osteoporosis, denosumab is usually initiated after a definitive diagnosis of osteoporosis (e.g., via **DEXA scan**) and often after lifestyle modifications and basic supplementation like vitamin D. It's a treatment, not a "most likely prescribed after additional investigation" first step.
*Atorvastatin*
- **Atorvastatin** is a statin used to lower cholesterol and prevent cardiovascular disease.
- While the patient has hypertension, there's no indication in the provided information (e.g., lipid profile, history of cardiovascular events) that she requires atorvastatin at this time.
*Tocopherol*
- **Tocopherol (Vitamin E)** is an antioxidant that plays a role in various bodily functions but is not directly involved in bone metabolism or the prevention/treatment of osteoporosis.
- There is no clinical indication in the patient's history suggesting a need for vitamin E supplementation for her current presentation.
Question 37: A 64-year-old African American female comes to the physician's office for a routine check-up. The patient's past medical history is significant for hypertension, diabetes, and osteoarthritis in her right knee. Her medications include metformin, glimepiride, lisinopril, metoprolol, hydrochlorothiazide, and ibuprofen as needed. Her only complaint is an unremitting cough that started about 3 weeks ago and she has noticed some swelling around her mouth. The drug most likely responsible for her recent symptoms causes its primary renal hemodynamic effect on which part of the kidney?
A. Collecting duct
B. Distal convoluted tubule
C. Juxtaglomerular cells
D. Efferent arteriole (Correct Answer)
E. Afferent arteriole
Explanation: ***Efferent arteriole***
- The patient's symptoms of an **unremitting cough** and **angioedema** (swelling around her mouth) are classic side effects of **ACE inhibitors**, such as **lisinopril**.
- ACE inhibitors primarily exert their renal hemodynamic effects by **dilating the efferent arteriole**, leading to a decrease in intraglomerular pressure and glomerular filtration rate.
*Collecting duct*
- The collecting duct is the primary site of action for **vasopressin (ADH)** and **aldosterone**, regulating water and sodium reabsorption, respectively.
- While other medications like **thiazides** (used by the patient) affect distal tubules and collecting ducts indirectly, their direct impact on the collecting duct is not the cause of angioedema or cough.
*Distal convoluted tubule*
- The distal convoluted tubule is the main site of action for **thiazide diuretics** (e.g., hydrochlorothiazide), which inhibit the Na-Cl cotransporter.
- This tubule segment is not directly involved in the mechanism leading to angioedema or cough caused by ACE inhibitors.
*Juxtaglomerular cells*
- Juxtaglomerular cells are responsible for producing **renin**, which is the initial step in the **renin-angiotensin-aldosterone system (RAAS)**.
- While ACE inhibitors block the conversion of angiotensin I to angiotensin II, they do not directly act on the juxtaglomerular cells themselves to cause their side effects.
*Afferent arteriole*
- The afferent arteriole is primarily regulated by **sympathetic tone** and local factors, and is the main site of action for medications like **NSAIDs** (e.g., ibuprofen, which the patient takes as needed).
- While NSAIDs cause **afferent arteriole constriction** and can impair renal function, they do not cause angioedema or a chronic cough.
Question 38: A 68-year-old man presents for his first hemodialysis treatment. He was diagnosed with progressive chronic kidney disease 6 years ago that has now resulted in end-stage renal disease (ESRD). He currently is on a waiting list for a kidney transplant. His past medical history is significant for hypertension and peptic ulcer disease, managed with amlodipine and esomeprazole, respectively. He has diligently followed a severely restricted diet. The patient is afebrile and his vital signs are normal. His latest serum creatinine gives him an estimated glomerular filtration rate (eGFR) of 12 mL/min/1.73 m2. Which of the following should be increased as part of the management of this patient?
A. Protein intake (Correct Answer)
B. Potassium intake
C. Sodium intake
D. Calcium intake
E. Fiber intake
Explanation: ***Protein intake***
- Once a patient with ESRD initiates **hemodialysis**, their protein requirements significantly increase due to protein losses during dialysis and increased catabolism.
- While patients with CKD not on dialysis have restricted protein intake, those on dialysis need about **1.2 g/kg/day** of protein to maintain a positive nitrogen balance.
*Potassium intake*
- Patients with ESRD commonly experience **hyperkalemia** due to impaired renal excretion.
- **Potassium intake** is typically restricted in dialysis patients to prevent life-threatening cardiac arrhythmias.
*Sodium intake*
- **Sodium restriction** is crucial for dialysis patients to manage fluid overload, hypertension, and prevent congestive heart failure.
- Increased sodium intake would exacerbate these conditions, leading to adverse outcomes.
*Calcium intake*
- Patients with ESRD often have complex mineral and bone disorders, including **hyperphosphatemia** and hypocalcemia.
- While calcium supplementation may be necessary for some, increasing dietary calcium generally is not the primary intervention and must be carefully balanced with phosphate binders to prevent vascular calcification.
*Fiber intake*
- While fiber is important for bowel health, there is no specific condition in this patient's profile that warrants a targeted increase in fiber intake in the context of starting hemodialysis.
- The most critical dietary adjustments for dialysis patients revolve around protein, fluid, and electrolytes.
Question 39: A 54-year-old man comes to the physician for a follow-up examination after presenting with elevated blood pressures on both arms at a routine visit 1 month ago. He feels well and takes no medications. He is 178 cm (5 ft 10 in) tall and weighs 99 kg (218 lb); BMI is 31 kg/m2. His pulse is 76/min, and blood pressure is 148/85 mm Hg on the right arm and 152/87 mm Hg on the left arm. Physical examination and laboratory studies show no abnormalities. The physician recommends lifestyle modifications in combination with treatment with hydrochlorothiazide. From which of the following embryological tissues does the site of action of this drug arise?
A. Pronephros
B. Mesonephros
C. Ureteric bud
D. Mesonephric duct
E. Metanephric blastema (Correct Answer)
Explanation: ***Metanephric blastema***
- Hydrochlorothiazide, a **thiazide diuretic**, acts primarily on the **distal convoluted tubule (DCT)** of the nephron.
- The DCT, along with the glomerulus, Bowman's capsule, proximal convoluted tubule, and loop of Henle, develops from the **metanephric blastema**.
*Pronephros*
- The **pronephros** is the earliest and most rudimentary kidney structure in human embryonic development, appearing around week 3.
- It is **non-functional** and quickly degenerates, not contributing to the definitive adult kidney structures.
*Mesonephros*
- The **mesonephros** develops after the pronephros and functions as an interim kidney during the first trimester.
- While it contributes to parts of the male genital system (e.g., **epididymis**, **vas deferens**), it does not form components of the adult kidney or the distal convoluted tubule.
*Ureteric bud*
- The **ureteric bud** (an outgrowth of the mesonephric duct) gives rise to the **collecting ducts, renal calyces, renal pelvis**, and **ureters**.
- It forms the **collecting system** of the kidney, but not the nephron's filter and reabsorption components like the distal convoluted tubule.
*Mesonephric duct*
- The **mesonephric duct (Wolffian duct)** is primarily involved in the development of the **male internal genitalia** (e.g., epididymis, vas deferens, seminal vesicles).
- In females, it largely **regresses**, and it does not contribute to the formation of the nephron or its tubules.
Question 40: A 33-year-old male presents to his primary care physician with complaints of headaches and muscle weakness. His physical exam is entirely within normal limits except for a blood pressure of 150/95. Subsequent routine blood lab work showed a sodium level of 146 and potassium level of 3.0. What is the best pharmacological therapy for this patient?
A. Fludrocortisone
B. Spironolactone (Correct Answer)
C. Lisinopril
D. Hydrochlorothiazide
E. Propranolol
Explanation: ***Spironolactone***
- This patient's symptoms (hypertension, **hypokalemia**, and **hypernatremia**) are classic for **primary hyperaldosteronism**. **Spironolactone** is an **aldosterone antagonist** that blocks the effects of aldosterone, effectively treating both the hypertension and electrolyte abnormalities.
- Aldosterone antagonists directly target the underlying pathology by countering the excessive mineralocorticoid activity, making it the most appropriate pharmacological therapy for primary hyperaldosteronism.
*Fludrocortisone*
- **Fludrocortisone** is a **mineralocorticoid** used to *replace* aldosterone in conditions like Addison's disease where aldosterone production is deficient.
- Administering fludrocortisone in a patient with excessive aldosterone (primary hyperaldosteronism) would worsen their condition by exacerbating hypertension, hypokalemia, and hypernatremia.
*Lisinopril*
- **Lisinopril** is an **ACE inhibitor** that works by blocking the conversion of angiotensin I to angiotensin II, leading to vasodilation and decreased aldosterone secretion.
- While ACE inhibitors can lower blood pressure, they are not the primary treatment for **primary hyperaldosteronism** because the condition involves autonomous aldosterone production **independent of the renin-angiotensin-aldosterone system (RAAS)**.
*Hydrochlorothiazide*
- **Hydrochlorothiazide** is a **thiazide diuretic** that works by increasing the excretion of sodium and water, thereby lowering blood pressure.
- However, thiazide diuretics also increase potassium excretion, which would further worsen the patient's existing **hypokalemia**, making it an inappropriate choice.
*Propranolol*
- **Propranolol** is a **non-selective beta-blocker** that lowers blood pressure by reducing heart rate and cardiac output.
- While useful for hypertension, beta-blockers do not address the underlying electrolyte disturbances characteristic of **primary hyperaldosteronism** and are not a first-line treatment for this specific condition.